Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

More US Positions Go As Daiichi Sankyo Refocuses

Executive Summary

Attempts to maximize the current commercial portfolio and prepare for upcoming pipeline launches spell more job losses at the US arm of major Japanese pharma Daiichi Sankyo.

Advertisement

Related Content

Daiichi's Quizartinib Looks To Join Novartis' Rydapt In AML
After Bad Data Comes Layoffs – Will The Next Job Cuts Be At Anthera?
Endgame For Singh Bros As India’s Top Court Upholds $550m Daiichi Arbitration Panel Award
Roxadustat To Overtake Epogen In Treating Anemia In CKD By 2021
Daiichi Closing Indian Site As Global Restructuring Continues
Daiichi Sankyo Lays Out Priorities As It Pursues Oncology Ambitions

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC100509

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel